1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with ADDH in 2 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glaser, PE | 1 |
| Surgener, SP | 1 |
| Grondin, R | 1 |
| Gash, CR | 1 |
| Palmer, M | 1 |
| Castellanos, FX | 1 |
| Gerhardt, GA | 1 |
| Roeltgen, DP | 1 |
| Schneider, JS | 1 |
2 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and ADDH
| Article | Year |
|---|---|
Cerebellar neurotransmission in attention-deficit/hyperactivity disorder: does dopamine neurotransmission occur in the cerebellar vermis?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; | 2006 |
Chronic low-dose MPTP in nonhuman primates: a possible model for attention deficit disorder.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Attention; Attention Deficit Disorder with Hy | 1991 |